These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Pharmacokinetics in stable kidney transplant recipients after conversion from twice-daily to once-daily tacrolimus formulations. van Hooff J; Van der Walt I; Kallmeyer J; Miller D; Dawood S; Moosa MR; Christiaans M; Karpf C; Undre N Ther Drug Monit; 2012 Feb; 34(1):46-52. PubMed ID: 22249344 [TBL] [Abstract][Full Text] [Related]
11. Once-daily tacrolimus extended release formulation: experience at 2 years postconversion from a Prograf-based regimen in stable liver transplant recipients. Florman S; Alloway R; Kalayoglu M; Punch J; Bak T; Melancon J; Klintmalm G; Busque S; Charlton M; Lake J; Dhadda S; Wisemandle K; Wirth M; Fitzsimmons W; Holman J; First MR Transplantation; 2007 Jun; 83(12):1639-42. PubMed ID: 17589349 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of tacrolimus converted from twice-daily formulation to once-daily formulation in Chinese stable liver transplant recipients. Zhang YF; Chen XY; Dai XJ; Leng XS; Zhong DF Acta Pharmacol Sin; 2011 Nov; 32(11):1419-23. PubMed ID: 21963896 [TBL] [Abstract][Full Text] [Related]
13. Two years postconversion from a prograf-based regimen to a once-daily tacrolimus extended-release formulation in stable kidney transplant recipients. Alloway R; Steinberg S; Khalil K; Gourishankar S; Miller J; Norman D; Hariharan S; Pirsch J; Matas A; Zaltzman J; Wisemandle K; Fitzsimmons W; First MR Transplantation; 2007 Jun; 83(12):1648-51. PubMed ID: 17589351 [TBL] [Abstract][Full Text] [Related]
14. First clinical experience with the new once-daily formulation of tacrolimus. First MR Ther Drug Monit; 2008 Apr; 30(2):159-66. PubMed ID: 18367975 [TBL] [Abstract][Full Text] [Related]
15. Once- versus twice-daily tacrolimus: are the formulations truly equivalent? Barraclough KA; Isbel NM; Johnson DW; Campbell SB; Staatz CE Drugs; 2011 Aug; 71(12):1561-77. PubMed ID: 21861541 [TBL] [Abstract][Full Text] [Related]
16. Influence of cytochrome P450 3A5 (CYP3A5) genetic polymorphism on the pharmacokinetics of the prolonged-release, once-daily formulation of tacrolimus in stable renal transplant recipients. Glowacki F; Lionet A; Hammelin JP; Labalette M; Provôt F; Hazzan M; Broly F; Noël C; Cauffiez C Clin Pharmacokinet; 2011 Jul; 50(7):451-9. PubMed ID: 21528942 [TBL] [Abstract][Full Text] [Related]
17. Trough level from twice daily to once daily tacrolimus in early conversion kidney transplant recipients: a prospective study. Sukkha S; Chindavijak B; Montakantikul P; Ingsathit A; Nosoongnoen W; Sumethkul V Int J Clin Pharm; 2017 Dec; 39(6):1298-1303. PubMed ID: 29101615 [TBL] [Abstract][Full Text] [Related]
18. Comparative pharmacokinetics of tacrolimus in stable pediatric allograft recipients converted from immediate-release tacrolimus to prolonged-release tacrolimus formulation. Rubik J; Debray D; Iserin F; Vondrak K; Sellier-Leclerc AL; Kelly D; Czubkowski P; Webb NJA; Riva S; D'Antiga L; Marks SD; Rivet C; Tönshoff B; Kazeem G; Undre N Pediatr Transplant; 2019 Jun; 23(4):e13391. PubMed ID: 30932313 [TBL] [Abstract][Full Text] [Related]
19. Conversion from twice-daily tacrolimus capsules to once-daily extended-release tacrolimus (LCPT): a phase 2 trial of stable renal transplant recipients. Gaber AO; Alloway RR; Bodziak K; Kaplan B; Bunnapradist S Transplantation; 2013 Jul; 96(2):191-7. PubMed ID: 23715050 [TBL] [Abstract][Full Text] [Related]
20. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts. Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]